Comparison
2q13 Microdeletion Syndrome C6012360 vs 16p12 2 Microdeletion Syndrome C4708497
Clinical comparison between 2q13 Microdeletion Syndrome and 16p12 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
16p12 2 Microdeletion Syndrome C4708497
A rare genetic condition where a small piece of chromosome 16 is missing. It can cause developmental delays, intellectual disability, and recurrent infections in some individuals. Treatment involves supportive therapies and medical management of symptoms.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
16p12 2 Microdeletion Syndrome C4708497
0-5
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
16p12 2 Microdeletion Syndrome C4708497
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
16p12 2 Microdeletion Syndrome C4708497
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
16p12 2 Microdeletion Syndrome C4708497
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
16p12 2 Microdeletion Syndrome C4708497
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
16p12 2 Microdeletion Syndrome C4708497
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 16p12-2-microdeletion-syndrome-C4708497 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 16p12 2 Microdeletion Syndrome C4708497 | Discriminating power |
|---|---|---|---|
| Development | Development may be affected; the specific pattern is not established. | Developmental delay and intellectual disability are described in some people. | Moderate |
| Infections | Recurrent infection is not established from the supplied description. | Recurrent infections are reported in some individuals. | Moderate |
| Recognition age | Onset is listed as variable. | Onset is listed from birth through age 5 years. | Low |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
Testing shows missing material at 2q13
The chromosomal locus identifies the condition more reliably than symptoms.
High
Severe congenital presentation with variable onset
This matches the supplied severity and onset, although overlap remains possible.
Moderate
Nonspecific features with confirmed 2q13 deletion
Distinctive features are mentioned but unspecified, so confirmation should guide labeling.
Moderate
Choose 16p12 2 Microdeletion Syndrome C4708497 when
Testing shows missing material at 16p12.2
A confirmed 16p12.2 deletion distinguishes this syndrome from a 2q13 deletion.
High
Early developmental delay with infections
These findings fit the supplied description, but they are not definitive alone.
Moderate
Moderate chronic presentation recognized by age 5
Supplied data list moderate severity and onset at ages 0–5.
Moderate
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 16p12 2 Microdeletion Syndrome C4708497 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion involving 2q13 when present | Deletion involving 16p12.2 when present | The locus distinguishes them; clinical correlation is required. |
| Karyotype | A small 2q13 deletion may be missed | A small 16p12.2 deletion may be missed | A normal karyotype does not exclude either microdeletion. |
| Targeted FISH or locus testing | Assesses a suspected 2q13 region | Assesses a suspected 16p12.2 region | Useful only when the target matches the suspected locus. |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- Long-term outcome is not established; supplied severity is severe and the course chronic.
- Factors
- Confirmed 2q13 deletion, developmental findings, and associated medical needs.
16p12 2 Microdeletion Syndrome C4708497
- Outcome
- Outcome is not established; supplied severity is moderate with a chronic course.
- Factors
- Developmental disability, infections in some, and access to supportive care.
Time frame: Lifelong follow-up; recognition may be variable or occur in early childhood.
Genetic result, individual symptoms, therapies, and clinician reassessment.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Possible, but extent is not established Delay or intellectual disability in some people Support needs should be individualized. |
| Infection-related illness | Not specifically established in the source data Recurrent infections reported in some individuals Do not assume infection risk for 2q13 from these data. |
| Other congenital findings | Distinctive features are possible but unspecified Additional features are not established here Specialist assessment should follow observed findings. |
Patient education highlights
- HighGenetic confirmation
The syndrome name should follow confirmed missing material at the relevant chromosomal region.
- HighSymptom-based care
Both conditions use supportive care and specialist management matched to observed needs.
- MediumLimits of current information
These sources do not establish prevalence, exact prognosis, or a uniform symptom list.